Region Genetic Association Analysis of Breast Cancer Patients With and Without Persistent Postsurgical Neuropathic Pain,” ...

Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...

The preliminary data from the open label arm indicates that approximately 46% of screened patients possess at least one HLA-A*02 allele. This arm is particularly focused on assessing the safety ...

Sacroiliitis was subsequently observed (Figure 1), and the diagnosis of HLA-B27-positive ankylosing spondylitis was made 6 years after the patient's rheumatologic symptoms first emerged.

EBV antibodies trigger MS by attacking brain proteins. Genetic factors worsen risk. Breakthrough insights for treatment.

New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...

The main purpose of the open label arm is to investigate the safety and efficacy of GLSI-100 vaccination in patients who do not have an HLA-A*02 allele. It is possible that the open label arm may ...

A preliminary review of FLAMINGO-01 HLA data in both the HLA-A*02 treated and placebo arms and the third open label arm with all other HLA types, shows that approximately 46% of all screened patients ...

Garuda Therapeutics (Garuda), a biotechnology company creating off-the-shelf, HSC therapies for a multitude of blood disorders, today announced the successful completion of an approximately $50 ...